Abstract
1. The alpha 1-adrenoceptor subtypes mediating contractions of the smooth muscle in human prostatic urethra and branches of internal iliac artery were characterized in isometric contraction experiments. 2. Phenylephrine produced concentration-dependent contractions in both the urethra and artery. These responses were competitively inhibited by prazosin, WB4101 and 5-methyl-urapidil, and the slopes of Schild plots for all these antagonists were close to unity. 3. The pA2 values for prazosin were not significantly different between the urethra (9.42 +/- 0.11; mean +/- s.d.) and artery (9.50 +/- 0.27), while the pA2 values for WB4101 and 5-methyl-urapidil in the human prostatic urethra (8.94 +/- 0.19 and 8.42 +/- 0.14, respectively) were significantly greater than in the branches of human internal iliac artery (7.94 +/- 0.21 and 7.43 +/- 0.22, respectively; P < 0.01). 4. Pretreatment with chlorethylclonidine (CEC) at concentrations ranging from 0.1 microM to 100 microM attenuated the maximum contraction to phenylephrine in a concentration-dependent manner in both the urethra and artery. However, the urethra was significantly less affected by CEC than the artery. The pD'2 values (negative logarithm of the molar concentration of antagonist which reduced the maximum contraction to one half) in the urethra and artery were 4.35 +/- 0.27 and 5.20 +/- 0.37, respectively (P < 0.01). 5. The present results indicate that there are distinct populations of alpha 1-adrenoceptor subtypes in the human prostatic urethra and branches of the internal iliac artery.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARIENS E. J., VAN ROSSUM J. M. pDx, pAx and pDx values in the analysis of pharmacodynamics. Arch Int Pharmacodyn Ther. 1957 Apr 1;110(2-3):275–299. [PubMed] [Google Scholar]
- ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aboud R., Shafii M., Docherty J. R. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br J Pharmacol. 1993 May;109(1):80–87. doi: 10.1111/j.1476-5381.1993.tb13534.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Awad S. A., Downie J. W., Lywood D. W., Young R. A., Jarzylo S. V. Sympathetic activity in the proximal urethra in patients with urinary obstruction. J Urol. 1976 May;115(5):545–547. doi: 10.1016/s0022-5347(17)59273-3. [DOI] [PubMed] [Google Scholar]
- Caine M., Pfau A., Perlberg S. The use of alpha-adrenergic blockers in benign prostatic obstruction. Br J Urol. 1976 Aug;48(4):255–263. doi: 10.1111/j.1464-410x.1976.tb03013.x. [DOI] [PubMed] [Google Scholar]
- Caine M., Raz S., Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol. 1975 Apr;47(2):193–202. doi: 10.1111/j.1464-410x.1975.tb03947.x. [DOI] [PubMed] [Google Scholar]
- Cotecchia S., Schwinn D. A., Randall R. R., Lefkowitz R. J., Caron M. G., Kobilka B. K. Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7159–7163. doi: 10.1073/pnas.85.19.7159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Furuya S., Kumamoto Y., Yokoyama E., Tsukamoto T., Izumi T., Abiko Y. Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol. 1982 Oct;128(4):836–839. doi: 10.1016/s0022-5347(17)53216-4. [DOI] [PubMed] [Google Scholar]
- Gross G., Hanft G., Rugevics C. 5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor. Eur J Pharmacol. 1988 Jul 7;151(2):333–335. doi: 10.1016/0014-2999(88)90819-9. [DOI] [PubMed] [Google Scholar]
- Gup D. I., Shapiro E., Baumann M., Lepor H. Autonomic receptors in human prostate adenomas. J Urol. 1990 Jan;143(1):179–185. doi: 10.1016/s0022-5347(17)39906-8. [DOI] [PubMed] [Google Scholar]
- Han C., Abel P. W., Minneman K. P. Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature. 1987 Sep 24;329(6137):333–335. doi: 10.1038/329333a0. [DOI] [PubMed] [Google Scholar]
- Han C., Abel P. W., Minneman K. P. Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine. Mol Pharmacol. 1987 Oct;32(4):505–510. [PubMed] [Google Scholar]
- Han C., Li J., Minneman K. P. Subtypes of alpha 1-adrenoceptors in rat blood vessels. Eur J Pharmacol. 1990 Nov 6;190(1-2):97–104. doi: 10.1016/0014-2999(90)94116-f. [DOI] [PubMed] [Google Scholar]
- Hedlund H., Andersson K. E., Ek A. Effects of prazosin in patients with benign prostatic obstruction. J Urol. 1983 Aug;130(2):275–278. doi: 10.1016/s0022-5347(17)51106-4. [DOI] [PubMed] [Google Scholar]
- Jardin A., Bensadoun H., Delauche-Cavallier M. C., Attali P. Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF Group. Lancet. 1991 Jun 15;337(8755):1457–1461. doi: 10.1016/0140-6736(91)93140-5. [DOI] [PubMed] [Google Scholar]
- Kawabe K., Ueno A., Takimoto Y., Aso Y., Kato H. Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group. J Urol. 1990 Oct;144(4):908–912. doi: 10.1016/s0022-5347(17)39620-9. [DOI] [PubMed] [Google Scholar]
- Kunisawa Y., Kawabe K., Niijima T., Honda K., Takenaka T. A pharmacological study of alpha adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra. J Urol. 1985 Aug;134(2):396–398. doi: 10.1016/s0022-5347(17)47185-0. [DOI] [PubMed] [Google Scholar]
- Leclerc G., Rouot B., Schwartz J., Velly J., Wermuth C. G. Studies on some para-substituted clonidine derivatives that exhibit an alpha-adrenoceptor stimulant activity. Br J Pharmacol. 1980;71(1):5–9. doi: 10.1111/j.1476-5381.1980.tb10902.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lepor H., Knapp-Maloney G., Sunshine H. A dose titration study evaluating terazosin, a selective, once-a-day alpha 1-blocker for the treatment of symptomatic benign prostatic hyperplasia. J Urol. 1990 Dec;144(6):1393–1398. doi: 10.1016/s0022-5347(17)39751-3. [DOI] [PubMed] [Google Scholar]
- Lepor H., Shapiro E. Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia. J Urol. 1984 Dec;132(6):1226–1229. doi: 10.1016/s0022-5347(17)50110-x. [DOI] [PubMed] [Google Scholar]
- Lepor H., Tang R., Meretyk S., Shapiro E. Alpha 1 adrenoceptor subtypes in the human prostate. J Urol. 1993 Mar;149(3):640–642. doi: 10.1016/s0022-5347(17)36170-0. [DOI] [PubMed] [Google Scholar]
- Lepor H., Tang R., Shapiro E. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle. Prostate. 1993;22(4):301–307. doi: 10.1002/pros.2990220404. [DOI] [PubMed] [Google Scholar]
- Lomasney J. W., Cotecchia S., Lorenz W., Leung W. Y., Schwinn D. A., Yang-Feng T. L., Brownstein M., Lefkowitz R. J., Caron M. G. Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J Biol Chem. 1991 Apr 5;266(10):6365–6369. [PubMed] [Google Scholar]
- McGuire J., Wagner F. M., Weiss R. M. Treatment of autonomic dysreflexia with phenoxybenzamine. J Urol. 1976 Jan;115(1):53–55. doi: 10.1016/s0022-5347(17)59065-5. [DOI] [PubMed] [Google Scholar]
- Minneman K. P., Han C., Abel P. W. Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. Mol Pharmacol. 1988 May;33(5):509–514. [PubMed] [Google Scholar]
- Morrow A. L., Creese I. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol. 1986 Apr;29(4):321–330. [PubMed] [Google Scholar]
- Perez D. M., Piascik M. T., Graham R. M. Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA. Mol Pharmacol. 1991 Dec;40(6):876–883. [PubMed] [Google Scholar]
- Price D. T., Schwinn D. A., Lomasney J. W., Allen L. F., Caron M. G., Lefkowitz R. J. Identification, quantification, and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate. J Urol. 1993 Aug;150(2 Pt 1):546–551. doi: 10.1016/s0022-5347(17)35544-1. [DOI] [PubMed] [Google Scholar]
- Schwinn D. A., Lomasney J. W., Lorenz W., Szklut P. J., Fremeau R. T., Jr, Yang-Feng T. L., Caron M. G., Lefkowitz R. J., Cotecchia S. Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J Biol Chem. 1990 May 15;265(14):8183–8189. [PubMed] [Google Scholar]
- Schwinn D. A., Lomasney J. W. Pharmacologic characterization of cloned alpha 1-adrenoceptor subtypes: selective antagonists suggest the existence of a fourth subtype. Eur J Pharmacol. 1992 Dec 1;227(4):433–436. doi: 10.1016/0922-4106(92)90162-o. [DOI] [PubMed] [Google Scholar]
- Suzuki E., Tsujimoto G., Tamura K., Hashimoto K. Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role. Mol Pharmacol. 1990 Nov;38(5):725–736. [PubMed] [Google Scholar]
- Takayanagi I., Harada M., Koike K., Satoh M. Differences in alpha 1-adrenoceptor mechanisms for phenylephrine and tizanidine in rabbit thoracic aorta and common iliac artery. Can J Physiol Pharmacol. 1991 Dec;69(12):1819–1824. doi: 10.1139/y91-269. [DOI] [PubMed] [Google Scholar]
- Testa R., Guarneri L., Ibba M., Strada G., Poggesi E., Taddei C., Simonazzi I., Leonardi A. Characterization of alpha 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur J Pharmacol. 1993 Nov 16;249(3):307–315. doi: 10.1016/0014-2999(93)90527-o. [DOI] [PubMed] [Google Scholar]